SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging after a preliminary business update revealed massive record-breaking order backlogs and a significant margin improvement that far exceeded previous guidance. This strong demand signal has fueled intense community discussion regarding a potential short squeeze, as investors weigh the company's aggressive growth against long-standing concerns regarding management and historical accounting scrutiny.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending due to heightened regulatory uncertainty as U.S. states, led by California, move to block its $110 billion merger with Warner Bros. Discovery on antitrust grounds. While the company is aggressively defending the deal as pro-competitive and essential for streaming scale, investors are closely monitoring potential litigation delays and the resulting financial ticking fees that are creating significant volatility.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending due to the announcement that Microsoft Azure will deploy its new Helios rack-scale AI systems, fueling a rally as the company expands its footprint in the hyperscale data center market. Investors are also actively debating the stock's valuation and potential upside ahead of the upcoming 'Advancing AI' conference, with community sentiment split between those calling for a continued breakout and those wary of institutional selling and broader sector volatility.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is seeing increased investor scrutiny as market participants weigh the company's long-term potential in renal care against concerns over reimbursement headwinds and the transition of its flagship product, DefenCath, into a post-incentive payment environment. The community remains divided, with some investors betting on growth from an expanded commercial footprint and pipeline assets, while others voice frustration over the stock's stagnant performance and management's communication strategy.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and the community spar over the platform's financial outlook, political controversy, and broader market concerns related to escalating geopolitical tensions. Discussions are intensely polarized, with users fiercely debating the company's business model, leadership, and the impact of national policies on market performance.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is seeing heightened market attention following the wet commissioning of its Montana critical minerals mill and continued progress on its domestic defense supply chain initiatives. While the community is debating the impact of ongoing market manipulation and short-selling dynamics, bulls remain focused on the company's status as a key domestic producer for defense-related antimony and tungsten contracts.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum is experiencing significant investor interest driven by a combination of tight oil supply due to ongoing Middle East tensions and anticipation surrounding upcoming earnings. The community is actively debating the sustainability of energy momentum, with many traders closely monitoring crude oil price action as a key catalyst for potential breakouts.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending following reports that it will join a 200 million federal initiative backed by the Trump administration to accelerate nuclear reactor deployment for AI data centers. While some community members are bullish on the company's long-term potential as a critical AI power backbone, others remain skeptical, citing ongoing regulatory hurdles, insider selling, and the long road to commercial revenue.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is experiencing high volatility as investors closely monitor fluctuating crude oil prices driven by shifting geopolitical developments between the U.S. and Iran. The community is actively debating the potential impact of ongoing peace negotiations and regional supply logistics on the leveraged ETF's momentum.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is experiencing heightened retail interest and volatility following the completion of enrollment for its Phase 3 APPROACH trial ahead of schedule, fueling anticipation for a pivotal data readout in the final quarter of 2026. The community is actively debating the company's long-term commercialization strategy, potential for industry M&A, and the impact of recent leadership changes on the firm's financial trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock?

DBV Technologies (DBVT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the five brokerages that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and three hav...

Pharming Group (OTCMKTS:PHGUF) Shares Gap Up - Time to Buy?

Pharming Group (OTCMKTS:PHGUF) Shares Gap Up - Here's What Happened...

Pharming Group (PHAR) Expected to Announce Quarterly Earnings on Thursday

Pharming Group (NASDAQ:PHAR) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-pharming-group-stock...

Pharming Group (PHGUF) to Release Quarterly Earnings on Thursday

Pharming Group (OTCMKTS:PHGUF) will be releasing earnings before the market opens on Thursday, May 7. (View Earnings Report at...

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Significant Decline in Short Interest

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) was the target of a large decline in short interest in the month of April. As of April 15th, there was short interest totaling 9,179...

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Large Decline in Short Interest

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) was the recipient of a significant drop in short interest in March. As of March 31st, there was short interest totaling 12,882...

Pharming Group (NASDAQ:PHAR) Sees Large Volume Increase  - Here's What Happened

Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - What's Next...

Pharming Group (OTCMKTS:PHGUF) Shares Gap Up   - Should You Buy?

Pharming Group (OTCMKTS:PHGUF) Shares Gap Up - Still a Buy...

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Receives Average Recommendation of "Hold" from Brokerages

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) has been given an average recommendation of "Hold" by the five analysts that are presently covering the firm, Marketbeat.com reports...

This account has been verified as an official PHAR representative.

Verified Account

Pharming Group IR

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.

Pharming Group N.V. - ADR

Pharming Stock Draws Retail Buzz After FDA Seeks More Data For Pediatric Immune Drug — Why Investors Aren’t Panicking

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

PHARPharming Group

Latest PHAR News